triamterene has been researched along with Obstructive Lung Diseases in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weinberg, MS | 1 |
| Quigg, RJ | 1 |
| Salant, DJ | 1 |
| Bernard, DB | 1 |
1 other study available for triamterene and Obstructive Lung Diseases
| Article | Year |
|---|---|
Anuric renal failure precipitated by indomethacin and triamterene.
Topics: Acute Kidney Injury; Aged; Angina Pectoris; Anuria; Drug Interactions; Female; Humans; Indomethacin; | 1985 |